A carregar...
Annual Bleeding Rates: Pitfalls of Clinical Trial Outcomes in Hemophilia Patients
Emerging treatment options for hemophilia, including gene therapy, modified factor products, antibody‐based products, and other nonreplacement therapies, are in development or on their way to marketing authorization. For proof of efficacy, annual bleeding rates (ABRs) have become an increasingly imp...
Na minha lista:
| Publicado no: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719362/ https://ncbi.nlm.nih.gov/pubmed/32472976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12794 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|